MORPHOLOGICAL AND MORPHOMETRIC ANALYSIS OF MICROANGIOPATHY AND FIBROSIS IN THE SYNOVIAL MEMBRANE UNDER EXPERIMENTAL DIABETES MELLITUS

This comprehensive study delves into the morphological and morphometric alterations induced by experimental diabetes mellitus (DM) in the synovial membrane, with a particular emphasis on microangiopathy and fibrosis. Employing a streptozotocin (STZ)-induced diabetic rat model, we conducted detailed examinations of microvessel architecture, basement membrane (BM) thickness, endothelial cell integrity, pericyte coverage, vascular density, and fibrotic tissue deposition across an 8-week timeline. Through advanced histological staining techniques, transmission electron microscopy (TEM), and quantitative morphometric analyses, significant findings included BM thickening by up to 2-3 fold, a 15-20% reduction in capillary density, pronounced endothelial cell swelling, pericyte degeneration, and elevated collagen fiber accumulation in diabetic cohorts relative to controls. These pathological shifts were closely linked to heightened oxidative stress indicators, such as nitrotyrosine expression, and inflammatory cell infiltration, indicative of a progressive microangiopathic process that culminates in synovial dysfunction. The observed fibrosis, characterized by increased perivascular collagen deposition and myofibroblast activation, likely exacerbates joint rigidity and contributes to diabetic arthropathy phenotypes. Morphometric quantifications revealed a temporal escalation, with fibrotic areas expanding 2-3 times by the study's end. This investigation not only illuminates the musculoskeletal ramifications of DM beyond traditional target organs but also posits potential therapeutic avenues, including antioxidant therapies or anti-fibrotic agents to mitigate vascular and tissue remodeling. By integrating ultrastructural insights with immunohistochemical profiling, the study affirms hyperglycemia's role in synovial pathology while acknowledging multifactorial influences like advanced glycation end-products (AGEs) and cytokine dysregulation. Ultimately, these results advocate for proactive vascular safeguarding in DM management to avert joint comorbidities, extending prior observations in atypical microvascular territories and underscoring the necessity for longitudinal human studies.

Hali tarjima qilinmagan